American International Group’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,883
Closed -$27.9K 2157
2024
Q1
$27.9K Sell
1,883
-17
-0.9% -$237 ﹤0.01% 2888
2023
Q4
$36.3K Sell
1,900
-7
-0.4% -$171 ﹤0.01% 2877
2023
Q3
$51.4K Buy
1,907
+68
+4% +$2.95K ﹤0.01% 2808
2023
Q2
$83.3K Buy
1,839
+704
+62% +$34.5K ﹤0.01% 2693
2023
Q1
$51.9K Buy
1,135
+46
+4% +$2.38K ﹤0.01% 2709
2022
Q4
$57.2K Buy
1,089
+142
+15% +$8.38K ﹤0.01% 2709
2022
Q3
$110K Buy
947
+14
+2% +$1.25K ﹤0.01% 2497
2022
Q2
$56K Sell
933
-190
-17% -$14.3K ﹤0.01% 2837
2022
Q1
$63K Buy
1,123
+645
+135% +$53.4K ﹤0.01% 2762
2021
Q4
$36K Sell
478
-14
-3% -$1.63K ﹤0.01% 3031
2021
Q3
$69K Buy
+492
New +$57.7K ﹤0.01% 2925

Other funds holding RLYB

American International Group's RLYB Position: Q2 2024 in Review

American International Group sold out of Rallybio (RLYB) in Q2 2024, closing a stake of 1,883 shares — an estimated $27.9K sold.

American International Group first reported a position in RLYB in Q3 2021 and held it in 11 quarters. The position peaked at $110K in Q3 2022. 66 funds tracked by Wall St. Rank hold RLYB as of Q2 2024.

  • American International Group reported no remaining Rallybio position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,883 Rallybio shares in Q2 2024, an estimated $27.9K.
  • American International Group first reported a position in Rallybio in Q3 2021 and held it in 11 quarters.
  • American International Group's Rallybio position peaked at $110K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Rallybio as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.